CDCA7 is frequently overexpressed in human cancers [93], including a large variety of B- and T-cell leukemias and lymphomas, and its loss has been shown to reduce T- and B-lymphomagenesis in vivo [94,95]. The gene discussed is CDCA7; the disease is lymphoma.